Identification of Protein Expression Signatures Associated with Helicobacter pylori Infection and Gastric Adenocarcinoma Using Recombinant Antibody Microarrays*

Antibody microarray based technology is a powerful emerging tool in proteomics, target discovery, and differential analysis. Here, we report the first study where recombinant antibody fragments have been used to construct large scale antibody microarrays, composed of 127 different antibodies against mostly immunoregulatory antigens. The arrays were based on single framework recombinant antibody fragments (SinFabs) designed for high on-chip stability and functionality and were used for the analysis of malignant and normal stomach tissue samples from Helicobacter pylori-positive and -negative patients. Our results demonstrate that distinct tumor- as well as infection-associated protein expression signatures could be identified from these complex tissue proteomes, as well as biomarkers such as IL-9, IL-11, and MCP-4, previously not found in these diseases. In a longer perspective, this study may improve the understanding of H. pylori-induced stomach cancer and lead to development of improved diagnostics.

[1]  A. Svennerholm,et al.  The local and systemic T-cell response to Helicobacter pylori in gastric cancer patients is characterised by production of interleukin-10. , 2007, Clinical immunology.

[2]  Johan Ingvarsson,et al.  Design of recombinant antibody microarrays for complex proteome analysis: Choice of sample labeling‐tag and solid support , 2007, Proteomics.

[3]  C. Borrebaeck,et al.  Antibody microarray-based oncoproteomics , 2006, Expert opinion on biological therapy.

[4]  R. Christopherson,et al.  Multiplex detection of surface molecules on colorectal cancers , 2006, Proteomics.

[5]  G. Watkins,et al.  Angiomotin and angiomotin like proteins, their expression and correlation with angiogenesis and clinical outcome in human breast cancer , 2006, BMC Cancer.

[6]  Ziding Feng,et al.  Antibody microarray profiling reveals individual and combined serum proteins associated with pancreatic cancer. , 2005, Cancer research.

[7]  H. Nagawa,et al.  Transactivation of epidermal growth factor receptor is involved in leptin-induced activation of janus-activated kinase 2 and extracellular signal-regulated kinase 1/2 in human gastric cancer cells. , 2005, Cancer research.

[8]  A. Tarnawski,et al.  Leptin activates STAT and ERK2 pathways and induces gastric cancer cell proliferation. , 2005, Biochemical and biophysical research communications.

[9]  Ziding Feng,et al.  Optimized Normalization for Antibody Microarrays and Application to Serum-Protein Profiling*S , 2005, Molecular & Cellular Proteomics.

[10]  Hirofumi Nakayama,et al.  Molecular-pathological prognostic factors of gastric cancer: a review , 2005, Gastric Cancer.

[11]  Brian B Haab,et al.  Antibody Arrays in Cancer Research , 2005, Molecular & Cellular Proteomics.

[12]  Johan Ingvarsson,et al.  Microarrays based on affinity‐tagged single‐chain Fv antibodies: Sensitive detection of analyte in complex proteomes , 2005, Proteomics.

[13]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[14]  A. Svennerholm,et al.  Mucosal FOXP3-Expressing CD4+ CD25high Regulatory T Cells in Helicobacter pylori-Infected Patients , 2005, Infection and Immunity.

[15]  J. Houghton,et al.  Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. , 2004, Gene.

[16]  C. Borrebaeck,et al.  High-throughput proteomics using antibody microarrays , 2004, Expert review of proteomics.

[17]  E. Kubista,et al.  Use of High-Throughput Protein Array for Profiling of Differentially Expressed Proteins in Normal and Malignant Breast Tissue , 2004, Breast Cancer Research and Treatment.

[18]  H. Isomoto,et al.  Enhanced Expression of Interleukin-8 and Activation of Nuclear Factor Kappa-B in Endoscopy-negative Gastroesophageal Reflux Disease , 2004, American Journal of Gastroenterology.

[19]  R. Christopherson,et al.  Identification of repertoires of surface antigens on leukemias using an antibody microarray , 2003, Proteomics.

[20]  C. V. D. van de Velde,et al.  Gastric cancer: epidemiology, pathology and treatment. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  Johan Ingvarsson,et al.  Recombinant antibody microarrays—a viable option? , 2003, Nature Biotechnology.

[22]  E. B. Butler,et al.  Antibody microarray profiling of human prostate cancer sera: Antibody screening and identification of potential biomarkers , 2003, Proteomics.

[23]  J. Hoheisel,et al.  Antibody microarrays: promises and problems. , 2002, BioTechniques.

[24]  Gavin MacBeath,et al.  Protein microarrays and proteomics , 2002, Nature Genetics.

[25]  C. Borrebaeck,et al.  Single framework recombinant antibody fragments designed for protein chip applications. , 2002, BioTechniques.

[26]  A. Nanashima,et al.  Increased expression of sialyl Lewis(x) antigen in penetrating growth type A early gastric cancer. , 2002, Journal of experimental & clinical cancer research : CR.

[27]  E. Huebner,et al.  Tissue rotation chamber for electrophysiology, microinjection, and microdissection. , 2002, BioTechniques.

[28]  E. Kitano,et al.  Synthesis of factor D by gastric cancer-derived cell lines. , 2002, International immunopharmacology.

[29]  I. Beales.  Effect of Interlukin-1β on proliferation of gastric epithelial cells in culture , 2002, BMC Gastroenterology.

[30]  H. Tonouchi,et al.  Profile of Monocyte Chemoattractant Protein-1 Circulating Levels in Gastric Cancer Patients , 2002, Scandinavian journal of gastroenterology.

[31]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[32]  L. Liotta,et al.  Proteomic profiling of the cancer microenvironment by antibody arrays , 2001, Proteomics.

[33]  Y. Kakeji,et al.  Tumor Growth Patterns and Biological Characteristics of Early Gastric Carcinoma , 2001, Oncology.

[34]  D. Graham,et al.  Relation between Cytokines and Helicobacter pylori in Gastric Cancer , 2001, Helicobacter.

[35]  R. Christopherson,et al.  Immunophenotyping of leukemias using a cluster of differentiation antibody microarray. , 2001, Cancer research.

[36]  D. Henson,et al.  Biomarkers for early detection of colon cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[38]  K. Bodger,et al.  Interleukin 10 in Helicobacter pylori associated gastritis: immunohistochemical localisation and in vitro effects on cytokine secretion , 2001, Journal of clinical pathology.

[39]  T. Borody,et al.  Shift of the gastric T‐cell response in gastric carcinoma , 2001, Journal of gastroenterology and hepatology.

[40]  P. Brown,et al.  Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions , 2001, Genome Biology.

[41]  S. Schreiber,et al.  Printing proteins as microarrays for high-throughput function determination. , 2000, Science.

[42]  E. Söderlind,et al.  Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries , 2000, Nature Biotechnology.

[43]  H. Lönroth,et al.  Local Cytokine Response in Helicobacter pylori-Infected Subjects , 1998, Infection and Immunity.

[44]  H. Lönroth,et al.  Specific Antibodies in Sera and Gastric Aspirates of Symptomatic and Asymptomatic Helicobacter pylori-Infected Subjects , 1998, Clinical Diagnostic Laboratory Immunology.

[45]  Y. Yamaoka,et al.  Chemokines in the gastric mucosa in Helicobacter pylori infection , 1998, Gut.

[46]  I. Beales,et al.  STIMULATION OF IL-8 PRODUCTION IN HUMAN GASTRIC EPITHELIAL CELLS BYHELICOBACTER PYLORI, IL-1β AND TNF-α REQUIRES TYROSINE KINASE ACTIVITY, BUT NOT PROTEIN KINASE C , 1997 .

[47]  K. Bodger,et al.  Gastric mucosal secretion of interleukin-10: relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. , 1997, Gut.

[48]  T. Sawada,et al.  Prognostic value of vascular endothelial growth factor expression in gastric carcinoma , 1996, Cancer.

[49]  Johan Ingvarsson,et al.  One-step fractionation of complex proteomes enables detection of low abundant analytes using antibody-based microarrays. , 2006, Journal of proteome research.

[50]  M. Blaser,et al.  Helicobacter pylori and gastrointestinal tract adenocarcinomas , 2002, Nature Reviews Cancer.

[51]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[52]  I. Fidler,et al.  Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. , 1998, The American journal of pathology.

[53]  I. Beales,et al.  Stimulation of IL-8 production in human gastric epithelial cells by Helicobacter pylori, IL-1beta and TNF-alpha requires tyrosine kinase activity, but not protein kinase C. , 1997, Cytokine.

[54]  Robert C. Wolpert,et al.  A Review of the , 1985 .